After the virus has cleared—can preclinical models be employed for long covid research?

HIGHLIGHTS

• who: Ethan B. Jansen and colleagues from the Vaccine and Infectious Disease Organization VIDO, University of, Saskatoon, Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada have published the paper: After the virus has clearedu2014Can preclinical models be employed for Long COVID research?, in the Journal: (JOURNAL)
• what: The authors discuss how the models can be leveraged for treatment evaluation including pharmacological agents that are currently in human clinical trials for treating Long COVID. The aim of this review is to highlight Long COVID preclinical animal models that could be used for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.